* FT : Clean energy will be critical to winning the AI race with China
Rather than choosing one energy source over another, the US must quickly create the conditions for a mix to meet demand
* FT : Darktrace CEO: ‘We didn’t have the valuation we knew we could get’
Jill Popelka has tried to strengthen the cyber company’s operations and cast off the shadow of early backer Mike Lynch
* FT : Maltese ‘golden’ passports were sold to Russians with Ukraine war links
Paid-for citizenship that could be banned by European court was handed to people who later faced sanctions
* FT : European airlines’ emissions on course to exceed pre-pandemic levels
Environmental data shows carbon dioxide from flights has risen, as airlines struggle to decarbonise
* FT : Swiss franc surge sparks bets on return to negative interest rates
Switzerland’s currency has soared as investors seek a haven from US President Donald Trump’s trade war
* FT : Vestas warns wind industry is falling behind global climate goals
Europe’s largest turbine maker notes ‘big discrepancy’ between ambitious targets and reality on the ground
* FT : Zealand Pharma says obesity drug deal with Roche will help it stay independent
Danish biotech is developing petrelintide in partnership with the Swiss pharma group
* FT : Saudi Aramco steps up e-fuel investment to prolong combustion engine era
World’s largest oil company says synthetic fuels have a part to play despite global shift towards electric vehicles
* FT : DeepMind UK staff seek to unionise and challenge defence deals and Israel links
Move by employees at Google’s AI arm follows discontent after weapons and surveillance pledge is dropped
* FT : US stocks underperform rest of world by widest margin since 1993
Investors fear Trump’s tariff blitz will lead to US stagflation while weak dollar adds to woes
* FT : Barbarians at the sluice gate: KKR’s Thames Water quest
US private equity firm is preferred bidder for UK utility trying to avert renationalisation
* FT : Deliveroo opens door to £2.7bn meal deal with DoorDash
UK food delivery group valued at £7.6bn in London listing four years ago
* FT : Dan Loeb’s Third Point builds stake in maker of Tylenol and Neutrogena
Johnson & Johnson spin-off Kenvue may become takeover target as activists circle the consumer health group